Trial Profile
Pilot Trial of Humanized 3S193 Monoclonal Antibody (hu3S193) in Presurgical Patients With Ovarian Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2014
Price :
$35
*
At a glance
- Drugs Anti-Lewis-Y transduced T cells (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 15 Oct 2014 New trial record